ATI RN
ATI Pharmacology Quiz Questions
Extract:
Question 1 of 5
A nurse is caring for a client who has chronic renal disease and is receiving therapy with epoetin alfa (Epogen). Which of the following laboratory results would the nurse assess for to determine therapeutic effectiveness?
Correct Answer: C
Rationale: Epoetin alfa stimulates red blood cell production, so hemoglobin and hematocrit levels indicate therapeutic effectiveness, unlike liver enzymes, leukocytes, or clotting factors.
Question 2 of 5
The nurse understands that neomycin may cause serious adverse effects such as HepatotoxicityCardiotoxicityDermatotoxicityNeurotoxicityOtotoxicityHemotoxicity and HepatotoxicityCardiotoxicityNephrotoxicityDermatotoxicityOtotoxicityHemotoxicity.
Correct Answer: D,G
Rationale: Neomycin, an aminoglycoside, can cause neurotoxicity (e.g., muscle weakness) and nephrotoxicity (kidney damage), particularly in infants, unlike other listed effects.
Question 3 of 5
A nurse is instructing a client who is newly diagnosed with pulmonary tuberculosis (TB) about the use of antitubercular medications. Which of the following information should the nurse include in the teaching?
Correct Answer: C
Rationale: TB treatment typically lasts 6-12 months to ensure complete bacterial eradication, preventing resistance, unlike lifelong treatment or Mantoux test reliance.
Question 4 of 5
A nurse is teaching a client who is beginning highly active antiretroviral therapy (HAART) for HIV which includes zidovudine (Retrovir). The nurse should include teaching regarding which black box warning associated with this medication?
Correct Answer: B
Rationale: Zidovudine has a black box warning for lactic acidosis, a life-threatening condition, unlike tendon rupture, nephrotoxicity, or thromboembolism.
Question 5 of 5
The nurse is caring for a client receiving ciprofloxacin (Cipro) for treatment of a urinary tract infection (UTI). The nurse will include which black box warning (BBW) in the discharge education?
Correct Answer: A
Rationale: Ciprofloxacin carries a black box warning for tendon rupture, particularly in high-risk groups, unlike thrombocytopenia, thromboembolism, or endometrial cancer.